Friday, February 05, 2021 7:46:21 PM
Share Structure:
Outstanding Shares as of 2/1
27,019,627
Held at DTC (FLOAT)
9,928,889
Restricted 16,243,536
Unrestricted 10,776,091
https://www.otcmarkets.com/stock/KOAN/security
Shareholder update:
https://www.businesswire.com/news/home/20201217005347/en/Resonate-Blends-Inc.-Announces-Q1-Launch-For-Its-KOAN-Cordials-Product-Line
Website:
https://www.koan.life/cordials
https://www.resonateblends.com/about
CEO Interview:
https://podcasts.apple.com/us/podcast/otcqb-podcast/id1193668018?i=1000506685652
Twitter updates:
$KOAN is an innovative Cannabis brand-focused company. Fully-reporting OTCQB company. We feel a controlled capital structure will bring shareholder value once our true market valuation is realized
$KOAN - We are pleased to announce we have begun the process of executing on the launch of our innovative Koan Cordials which will ship in first quarter of next year. KOAN® is the brand name for our first family of cannabis products targeting the Wellness Lifestyle market
$KOAN - since we took control of the holding company, we have paid off all toxic convertible debt - with two amortized payment notes remaining. Important as we continue to execute on our business plan
$KOAN is an innovative Cannabis brand-focused company. Fully-reporting OTCQB company. We feel a controlled capital structure will bring shareholder value once our true market valuation is realized #CannabisCommunity #CannabisCulture #CannabisStocks https://t.co/Av1z1KRMuQ pic.twitter.com/f3yuNwgJDt
— Resonate Blends (@Resonate_KOAN) January 29, 2021
Investment Banker:
Boustead Securities, LLC
https://www.businesswire.com/news/home/20200519005197/en/Resonate-Blends-Inc.-Engages-Boustead-Securities-LLC-as-Investment-Bankers-and-Financial-Advisors
Recent KOAN News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 04:51:05 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/25/2024 09:03:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:28:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 08:22:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 11:03:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 10:05:51 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 03:08:06 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM